跳至主要内容
临床试验/NCT01141894
NCT01141894终止不适用

Evaluation of Costs and Consequences of Alternative Strategies of Intraoperative Fluid and Pharmacological Optimization. A Randomized Clinical Trial

Karolinska Institutet2 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2010年3月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
150
试验地点
2
主要终点
number of patients with postoperative complications

研究概览

简要总结

The investigators aimed to compare the costs and consequences of 'routine perioperative fluid therapy' and 'GDHT in terms of morbidity, mortality, length of hospital stay, activity of daily living, health related quality of life, cognitive functions and need of social services and up till 12 months following operations of proximal femoral fracture at elderly. The primary hypothesis is that 'GDHT is a better strategy than 'routine fluid therapy' in terms of reduced frequency of postoperative complications.

详细描述

The investigation is an open, randomized clinical study of individuals suffering from a proximal femoral fracture. The total study duration for each subject is approximately 12 months (+- 1 month); each patient will have 4'visits' (i.e. when PI extracts data to database) including regular praxis total: at registration; at discharge; 4 months and finally at 12 months after the surgery. For practical and logistic reasons, an interim-analysis will be conducted after approximately 100 patients whose data are completed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
70 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients (men and women) age ≥ 70 years
  • Patients´ scheduled for operation of proximal femoral fracture during office hours
  • Patient who have a witnessed or written informed consent

排除标准

  • Any of the following is regarded as a criterion for exclusion from the study:
  • Concomitant medication with Lithium
  • Known allergy (or hypersensitivity) to Lithium, or components of the medical device
  • Weight ≤ 40 kg
  • Other conditions or symptoms preventing the subject from entering the study, according to investigators judgment
  • Life expectancy less than 6 months and/or pathological fractures
  • Not possible to insert arterial line.

结局指标

主要结局

number of patients with postoperative complications

时间窗: up to 2 weeks

absolute value, number

次要结局

  • health related quality of life(12 months)
  • haemodynamic parameters(baseline)
  • Health Related Quality of Life(1 year)
  • number of complications(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Erzsebet Bartha

Medical Doctor

Karolinska Institutet

研究点 (2)

Loading locations...

相似试验